Inventor
KIRBY IAN
GB27 patents
⚠️ This page may combine multiple inventors who share the name “KIRBY IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYMAB LTD
22 patentsUS9567399B1Feb 14, 2017
Antibodies and immunocytokines
KYMAB LTD96 citations98
US9617338B1Apr 11, 2017
Antibodies and immunocytokines
KYMAB LTD78 citations97
US9139653B1Sep 22, 2015
Anti-human OX40L antibodies and methods of treatment
KYMAB LTD38 citations94
US10604576B2Mar 31, 2020
Antibodies and immunocytokines
KYMAB LTD25 citations92
US9957323B2May 1, 2018
Anti-ICOS antibodies
KYMAB LTD27 citations92
US9234043B1Jan 12, 2016
Anti-human OX40L antibodies
KYMAB LTD21 citations92
US9587030B2Mar 7, 2017
Anti-hOX40L antibodies, uses, and methods
KYMAB LTD14 citations91
US11396550B2Jul 26, 2022
Methods of treating comprising administering anti-OX40L antibodies
KYMAB LTD4 citations84
US9868789B2Jan 16, 2018
Synergistic combinations of OX40L antibodies for the treatment of GvHD
KYMAB LTD11 citations83
US9868790B2Jan 16, 2018
Synergistic combinations of OX40L antibodies for the treatment of GvHD
KYMAB LTD11 citations83
US9512229B2Dec 6, 2016
Synergistic combinations of OX40L antibodies for the treatment of GVHD
KYMAB LTD12 citations83
US10669342B2Jun 2, 2020
Anti-OX40L antibodies and methods of treating graft versus host disease
KYMAB LTD7 citations82
US10654935B2May 19, 2020
Methods of treating SLE with anti-OX40L antibodies
KYMAB LTD7 citations82
US9434785B1Sep 6, 2016
Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
KYMAB LTD16 citations80
US11773175B2Oct 3, 2023
Antibodies, uses and methods
KYMAB LTD1 citations73
US11965026B2Apr 23, 2024
Anti-PD-L1 and IL-2 cytokines
KYMAB LTD3 citations72
US10259880B2Apr 16, 2019
Anti-LIGHT antibodies
KYMAB LTD3 citations69
US11858996B2Jan 2, 2024
Anti-ICOS antibodies
KYMAB LTD2 citations68
US12209128B2Jan 28, 2025
Anti-PD-L1 antibodies
KYMAB LTD1 citations62
US11753479B2Sep 12, 2023
Nucleic acids encoding anti-OX40L antibodies
KYMAB LTD0 citations62
US11812731B2Nov 14, 2023
Animal models and therapeutic molecules
KYMAB LTD0 citations61
US11440960B2Sep 13, 2022
TIGIT antibodies, encoding nucleic acids and methods of using said antibodies in vivo
KYMAB LTD1 citations56